Ferring and Rebiotix to Present Landmark Data for Investigational Microbiota-based Live Biotherapeutic RBX2660 at Digestive Disease Week® (DDW) 2021
- by celiaFerring Pharmaceuticals and Rebiotix, a Ferring Company, today announced that Phase 3 data evaluating its investigational microbiota-based live biotherapeutic RBX2660 for reduction of recurrent Clostridioides difficile (C. difficile) infection will be presented…
celiaFerring appoints Jan Lundberg to Group Board
- by cajuFerring Pharmaceuticals announced today that Jan Lundberg has been appointed to the Ferring Group Board, effective January 2021, as a non-executive director and Chairman of the Research and Development Committee, following the retirement of John Patterson…
cajuFerring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health
- by celiaFerring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive…
celiaSimple Pharma acquires Testavan® and Vitaros®, two established men’s health brands, from Ferring
- by cajuBy divesting its rights to Simple Pharma on this transaction, Ferring is able to focus on areas of high unmet need to bring the most value to patients and healthcare professionals. Testavan® (transdermal testosterone gel 2%) is a testosterone…
caju“Standing together against injustice” – a message from Per Falk, President and Chief Science Officer at Ferring
- by pulse“Standing together against injustice” – a message from Per Falk, President and…
pulse
- 1
- 2